Dogwood Therapeutics, Inc.
DWTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818844
No open-market purchases or sales by Dogwood Therapeutics, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $6.16M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Dogwood Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- −1 vs. Q4 2021
- Shares held
- 1.10M
- +146.0K (+15.4%) vs. Q4 2021
- Total value
- $4.91M
- +$53.0K (+1.1%) vs. Q4 2021
- New holders
- 2
- 6 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DWTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $6.16M |
| Q1 2026 | 13 | $7.64M |
| Q4 2025 | 10 | $292.0K |
| Q3 2025 | 12 | $299.5K |
| Q2 2025 | 10 | $207.5K |
| Q1 2025 | 13 | $409.8K |
| Q4 2024 | 10 | $76.5K |
| Q3 2024 | 24 | $180.3K |
| Q2 2024 | 24 | $212.0K |
| Q1 2024 | 20 | $324.9K |
| Q4 2023 | 20 | $493.4K |
| Q3 2023 | 23 | $766.3K |
| Q2 2023 | 24 | $1.08M |
| Q1 2023 | 23 | $307.1K |
| Q4 2022 | 27 | $307.7K |
| Q3 2022 | 25 | $485.7K |
| Q2 2022 | 17 | $4.80M |
| Q1 2022 | 15 | $4.91M |
| Q4 2021 | 16 | $4.85M |
| Q3 2021 | 13 | $5.30M |
| Q2 2021 | 14 | $5.58M |
| Q1 2021 | 14 | $5.06M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Dogwood Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 46 | $0 | 0.00% | +1+2.2% | Added |
| Wolff Wiese Magana LLC | 52 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,687 | $8.00K | 0.00% | −164−8.9% | Reduced |
| Tower Research Capital LLC (TRC) | 2,636 | $12.0K | 0.00% | +2,606+8,686.7% | Added |
| Morgan Stanley | 4,638 | $21.0K | 0.00% | +4,638 | New |
| UBS Group AG | 14,137 | $63.0K | 0.00% | +11,887+528.3% | Added |
| Two Sigma Advisers, LP | 14,400 | $65.0K | 0.00% | −100−0.7% | Reduced |
| Northern Trust Corp | 15,117 | $68.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 17,464 | $78.0K | 0.00% | +17,464 | New |
| BlackRock Inc. | 17,768 | $80.0K | 0.00% | −873−4.7% | Reduced |
| Geode Capital Management, LLC | 31,595 | $141.0K | 0.00% | +9,031+40.0% | Added |
| Captrust Financial Advisors | 40,145 | $180.0K | 0.00% | 00.0% | Unchanged |
| Cetera Advisors LLC | 43,944 | $197.0K | 0.00% | +7,934+22.0% | Added |
| Vanguard Group Inc | 241,666 | $1.08M | 0.00% | +93,800+63.4% | Added |
| Masters Capital Management LLC | 650,000 | $2.91M | 0.49% | 00.0% | Unchanged |
| Tevis Investment Management | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −185−100.0% | Sold out |